Related Experiment Videos

Current status of the second-look operation in ovarian cancer

Clinics in Obstetrics and Gynaecology

|August 1, 1983

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo.

British journal of cancer·2014

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.

British journal of cancer·2013

Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial.

British journal of cancer·2013

Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays.

Oncogene·2012

Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.

British journal of cancer·2012

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.

Oncogene·2011

See all related articles